Literature DB >> 4199527

Sensitivity testing with trimethorpim-sulphamethoxazole.

S R Bushby.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4199527

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  7 in total

Review 1.  Principles of combination therapy.

Authors:  S Levin; A A Harris
Journal:  Bull N Y Acad Med       Date:  1975-10

Review 2.  Synergy of trimethoprim-sulfamethoxazole.

Authors:  S R Bushby
Journal:  Can Med Assoc J       Date:  1975-06-14       Impact factor: 8.262

3.  Thymidine-dependent Escherichia coli infection and some associated laboratory problems.

Authors:  E I Tanner; C H Bullin
Journal:  J Clin Pathol       Date:  1974-07       Impact factor: 3.411

4.  Is Streptococcus pyogenes resistant or susceptible to trimethoprim-sulfamethoxazole?

Authors:  Asha C Bowen; Rachael A Lilliebridge; Steven Y C Tong; Robert W Baird; Peter Ward; Malcolm I McDonald; Bart J Currie; Jonathan R Carapetis
Journal:  J Clin Microbiol       Date:  2012-10-10       Impact factor: 5.948

5.  Diffusion of trimethoprim and sulfamethoxazole from susceptibility disks into agar medium.

Authors:  M E Grace; S R Bushby; C W Sigel
Journal:  Antimicrob Agents Chemother       Date:  1975-07       Impact factor: 5.191

6.  Synergistic interaction of trimethoprim and sulfamethoxazole on Paracoccidioides brasiliensis.

Authors:  D A Stevens; P T Vo
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

7.  Effects of changes in pH, medium, and inoculum size on the in vitro activity of amifloxacin against urinary isolates of Staphylococcus saprophyticus and Escherichia coli.

Authors:  A Iravani; G S Welty; B R Newton; G A Richard
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.